Ignite Creation Date:
2024-05-05 @ 4:43 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00300612
Status:
COMPLETED
Last Update Posted:
2020-05-28
First Post:
2006-03-07
Brief Title:
Vaccine Treatment for Advanced Malignant Melanoma
Sponsor:
NewLink Genetics Corporation
Organization:
Lumos Pharma
Organization Data
Organization:
Lumos Pharma
Class:
INDUSTRY
Study ID:
NLG0104
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
NewLink Genetics Corporation
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Nicholas N Vahanian MD Chief Medical and Operations Officer
Old Organization:
NewLink Genetics Corporation